quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:39:16·107d
ANALYSTRating
Inventiva S.A. logo

UBS resumed coverage on Inventiva with a new price target

IVA· Inventiva S.A.
Health Care
Original source

Companies

  • IVA
    Inventiva S.A.
    Health Care

Recent analyst ratings

  • Mar 19UpdateTruist$13.00
  • Jan 28UpdateBarclays$18.00
  • Jan 12UpdateLeerink Partners$12.00
  • Jan 7UpdateUBS$12.00
  • Nov 6UpdateWolfe Research$13.00
  • Sep 3UpdateH.C. Wainwright$20.00

Related

  • SEC1d
    SEC Form 6-K filed by Inventiva S.A.
  • PR15d
    Inventiva announces filing of its 2025 Universal Registration Document and 2025 Annual Report on Form 20-F
  • SEC16d
    SEC Form 20-F filed by Inventiva S.A.
  • SEC24d
    SEC Form 6-K filed by Inventiva S.A.
  • PR24d
    Inventiva reports 2025 full year results and provides a business update
  • PR31d
    Inventiva Schedules the Publication and Presentation of its 2025 Full-Year Financial Results
  • ANALYST36d
    Truist initiated coverage on Inventiva with a new price target
  • PR56d
    Inventiva to Participate in Four Upcoming March Investor Conferences
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022